{
  "content": "Diagnosis:\nProstate adenocarcinoma with vacuolated cell features\nT2b N0 M0, diagnosed January 2024\nInitial PSA 8.9, PTEN monoallelic loss on genomic testing\n\nPrevious medical history:\nHypertension\nType 2 diabetes\n\nCurrent medications:\nBicalutamide 150mg daily\nLeuprorelin 3-monthly depot\nMetformin\nRamipril\n\nCurrent situation:\nPSA trend:\n8.9 (Jan 2024)\n0.8 (Mar 2024)\n0.4 (today)\n\nSeen for review following 3 months of hormone therapy. Tolerating treatment well with only grade 1 hot flushes. Performance status remains 0. No urinary symptoms. Digital rectal examination shows reduction in size of right-sided nodule. Latest testosterone confirms castrate level at 0.4nmol/L. Plan to continue current hormone therapy with PSA check and review in 3 months.",
  "output": {
    "primary_cancer": {
      "site": "prostate",
      "year": 2024,
      "month": 1,
      "metastases": null,
      "tnm_stage": "T2bN0M0",
      "histopathology_status": "adenocarcinoma with vacuolated cell features",
      "biomarker_status": "Initial PSA 8.9, PTEN monoallelic loss",
      "cancer_timeline": [
        {
          "type": "laboratory_finding",
          "value": "Initial PSA 8.9",
          "year": 2024,
          "month": 1
        },
        {
          "type": "treatment_systemic_start",
          "value": "Started on bicalutamide 150mg daily and leuprorelin depot",
          "year": 2024,
          "month": 1
        },
        {
          "type": "laboratory_finding",
          "value": "PSA decreased to 0.8",
          "year": 2024,
          "month": 3
        },
        {
          "type": "laboratory_finding",
          "value": "PSA further decreased to 0.4, testosterone confirms castrate level at 0.4nmol/L",
          "year": 2024,
          "month": null
        }
      ]
    },
    "patient_facts": [
      {
        "type": "comorbidity",
        "value": "Hypertension"
      },
      {
        "type": "comorbidity",
        "value": "Type 2 diabetes"
      },
      {
        "type": "performance_status",
        "value": "Performance status 0"
      },
      {
        "type": "examination_finding",
        "value": "Digital rectal examination shows reduction in size of right-sided nodule"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Localized prostate cancer responding well to hormone therapy with good PSA response and no significant toxicity"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "Grade 1 hot flushes"
      },
      {
        "type": "update_to_treatment",
        "value": "Continuing bicalutamide 150mg daily and leuprorelin 3-monthly depot"
      },
      {
        "type": "planned_investigation",
        "value": "PSA check in 3 months"
      },
      {
        "type": "follow_up_referral",
        "value": "Review in clinic in 3 months"
      }
    ]
  }
}